| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/29/2014 | CN103539855A Extraction method of acaudina molpadioidea collagen |
| 01/29/2014 | CN103539854A Extracorporeal dynamic circulation method for preparing advanced glycation end products |
| 01/29/2014 | CN103539853A Specific antibody for resisting atrazine herbicide |
| 01/29/2014 | CN103539852A Method for separating and purifying recombinant human coagulation factor VIII from cell culture fluid |
| 01/29/2014 | CN103539851A Generation of artificial binding proteins based on ubiquitin proteins |
| 01/29/2014 | CN103539850A Peptide separately separated from pig and use thereof |
| 01/29/2014 | CN103539849A Circular synthesized polypeptide D and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539848A Annular synthetic polypeptide A and application thereof in term of bacteria and virus resistance |
| 01/29/2014 | CN103539847A Cyclic synthetic peptide B, and antibacterial and antiviral application thereof |
| 01/29/2014 | CN103539846A Circular synthesized polypeptide F and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539845A Circular synthesized polypeptide E and antibacterial and antivirus application thereof |
| 01/29/2014 | CN103539844A Cyclic synthetic peptide C, and antibacterial and antiviral application thereof |
| 01/29/2014 | CN103539843A Method for producing sericin protein |
| 01/29/2014 | CN103539842A Recombinant protein coded by grass carp reovirus (GCRV) type-II S10 gene, polyclonal antibody prepared from recombinant protein and application of recombinant protein |
| 01/29/2014 | CN103539839A Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 01/29/2014 | CN102816816B Bacillus sphaericus parasporal crystal protein preparation method and application thereof |
| 01/29/2014 | CN102757489B Method for synchronously extracting and separating arachin and conarrachin |
| 01/29/2014 | CN102731642B Production technology of high-pure Apoa-I from fourth deposit of human blood plasma component |
| 01/29/2014 | CN102657847B Application of toad maggot protein in medicine used for treating rectal cancer |
| 01/29/2014 | CN102584984B Artificially synthesized cinnamaldehyde complete antigen and application thereof |
| 01/29/2014 | CN102492696B Recombinant toxoplasma protein and application thereof |
| 01/29/2014 | CN102464710B Helicoverpa armigera juvenile hormone binding protein (Ha-JHBP) and encoding gene and application thereof |
| 01/29/2014 | CN102382845B Method for producing porcine parvovirus antigen and its product |
| 01/29/2014 | CN101939443B Modified leptin polypeptides and their uses |
| 01/29/2014 | CN101842109B Peptides derivatized with A-B-C-D- and their therapeutical use |
| 01/29/2014 | CN101827933B Selective cell therapy for the treatment of renal failure |
| 01/29/2014 | CN101765610B Novel immunogenic epitopes for immunotherapy, preparation method and uses |
| 01/29/2014 | CN101743309B Modified factor vii polypetides and uses thereof |
| 01/29/2014 | CN101563361B Influenza viruses able to infect canids, uses thereof |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/28/2014 | US8637746 Maize variety hybrid X18A643 |
| 01/28/2014 | US8637737 Engineering of bolting resistance in sugar beet by means of the transgenic expression of the beet homologue of flowering time control gene FT |
| 01/28/2014 | US8637732 Plant MYB transcription factor homologs |
| 01/28/2014 | US8637646 Growth hormone variants |
| 01/28/2014 | US8637640 Blood coagulation protein conjugates |
| 01/28/2014 | US8637639 Method and composition for crystallizing G protein-coupled receptors |
| 01/28/2014 | US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 01/28/2014 | US8637484 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 01/28/2014 | US8637471 Fertilization prediction and promotion |
| 01/28/2014 | US8637470 Small humanin-like peptides |
| 01/28/2014 | US8637467 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 01/28/2014 | US8637462 Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist |
| 01/28/2014 | US8637458 Insulin with a stable basal release profile |
| 01/28/2014 | US8637456 Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| 01/28/2014 | US8637448 Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface |
| 01/28/2014 | US8637447 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 01/28/2014 | US8637315 Process, vectors and engineered cell lines for enhanced large-scale transfection |
| 01/28/2014 | US8637313 Production of viral vectors |
| 01/28/2014 | US8637305 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 01/28/2014 | US8637262 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 01/28/2014 | US8637255 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 01/28/2014 | US8637053 Chlamydia antigens |
| 01/28/2014 | US8637052 Klebsiella antigens |
| 01/28/2014 | US8637050 Peptide vaccines against group A streptococci |
| 01/28/2014 | US8637048 Immunizing compositions and methods of use |
| 01/28/2014 | US8637047 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | US8637042 Targeted particles and methods of using the same |
| 01/28/2014 | US8637039 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 01/28/2014 | US8637037 Allergens and allergoids from bee venom |
| 01/28/2014 | US8637034 Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| 01/28/2014 | US8637023 Hemojuvelin fusion proteins |
| 01/28/2014 | US8637020 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 01/28/2014 | US8637015 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 01/28/2014 | US8637012 Genetic products differentially expressed in tumors and the use thereof |
| 01/28/2014 | US8637007 Factor VIIa-polysialic acid conjugate having prolonged in vivo half-life |
| 01/28/2014 | US8637006 Recombinant vaccines and use thereof |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | CA2634647C Metastin derivatives and use thereof |
| 01/28/2014 | CA2611954C Dengue serotype 2 attenuated strain |
| 01/28/2014 | CA2599734C Humanized l243 antibodies |
| 01/28/2014 | CA2581983C Plant promoters and uses thereof |
| 01/28/2014 | CA2520382C Lupus antibodies for passive immunotherapy of hiv/aids |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2502690C Compstatin analogs with improved activity |
| 01/28/2014 | CA2492295C Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 01/28/2014 | CA2481799C Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 01/28/2014 | CA2456593C Peptides for the diagnosis, monitoring and treatment of diabetes |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/28/2014 | CA2307017C Erythropoietin-mediated neurogenesis |
| 01/25/2014 | CA2821384A1 Purification of cell culture derived alpha1 protease inhibitor |
| 01/23/2014 | WO2014015148A1 Human btnl3 proteins, nucleic acids, and antibodies and uses thereof |
| 01/23/2014 | WO2014015116A2 Novel arterivirus protein and expression mechanisms |
| 01/23/2014 | WO2014015091A2 Bovine influenza virus compositions |
| 01/23/2014 | WO2014014918A2 X-ding-cd4 peptide |
| 01/23/2014 | WO2014014897A2 Immunoglobulin-binding human mycoplasma antigens and methods of use thereof |
| 01/23/2014 | WO2014014796A1 Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains |
| 01/23/2014 | WO2014014410A1 Angiopoietin-like 4 and a method of its use in wound healing |
| 01/23/2014 | WO2014014206A1 Novel peptide tag and uses thereof |
| 01/23/2014 | WO2014013060A1 Osteopontin peptide fragments for use in suppression or prevention of tumor growth |
| 01/23/2014 | WO2014013039A1 Composition comprising a mixture of cd95-fc isoforms |
| 01/23/2014 | WO2014013037A1 Shortened cd95-fc variants |
| 01/23/2014 | WO2014013036A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/23/2014 | WO2014012683A1 Anti-inflammatory peptides and composition comprising the same |
| 01/23/2014 | WO2014012399A1 Recombinational lucid ganoderma immunomodulatory protein methoxypolyethyleneglycol propionic acid succinimidyl ester modifier, preparation method and use |
| 01/23/2014 | WO2014012312A1 Anti-inflammatory lipopeptide and preparing method and application thereof |
| 01/23/2014 | WO2013184962A4 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 01/23/2014 | WO2013173897A3 Gene, ars-r anchorage cassette, ars-r expression- anchorage cassette, recombinant plasmid, bacterial transgenic lineage, use of said gene, use of said lineage in environmental bioremediation processes |